Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

The authors define the “5 Love Languages,” (5LL), as: ...

Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...

A Cleveland Clinic expert explains the signs that indicate a dementia patient is nearing the end of their life.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Alzheimer's disease continues to be the most common form of dementia, affecting 50 million people worldwide. With no cure ...

Smoking and obesity synergistically worsened disease progression and cognitive performance in multiple sclerosis (MS) in a ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis ...